NCT04727827View on ClinicalTrials.gov

Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation

NACompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

June 9, 2023

Study Completion Date

June 9, 2023

Conditions

Hematopoietic Cell TransplantationOncology

Interventions

OTHER

Pharmacogenomic-guided supportive care

Patients undergoing hematopoietic stem cell transplantation will be genotyped and supportive care therapies tailored to identified drug-gene pairs and guideline recommendations

Trial Locations (1)

28204

Levine Cancer Institute, Charlotte

All Listed Sponsors

lead

Wake Forest University Health Sciences

OTHER

NCT04727827 - Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation | Biotech Hunter | Biotech Hunter